Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Apr;80(5):441-450.
doi: 10.1002/pros.23959. Epub 2020 Feb 6.

What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing

Affiliations
Multicenter Study

What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing

Samantha Greenberg et al. Prostate. 2020 Apr.

Abstract

Background: Guidelines have changed recently to include genetic counseling (GC) and/or genetic testing (GT) for all men with aggressive prostate cancer (PCa). This study aimed to identify what information men with PCa desire before and from GC.

Methods: Focus groups were conducted with men who have PCa. Audio recordings were analyzed for themes related to GT, the information they desired from health care providers, and implications for family members.

Results: Thirty-seven men with PCa participated in seven focus groups. Nearly all men felt GT was beneficial and impactful for their family and themselves. Most men were unaware of the risks to female relatives associated with hereditary cancer. Participants discussed that genetics should be incorporated at an appropriate time of their diagnostic journey.

Conclusion: This study showed that men valued GC and GT for personal and familial implications, and often did not associate PCa genetics with risk for female relatives to develop cancer. Consideration should be given to the GC timing in regard to where men are in their treatment process. Providers referring patients can leverage patient motivations and utilize their relationship with the patient to determine the appropriate timing and personalize discussion with the patient regarding GC and GT.

Keywords: BRCA1/2; genetic counseling; germline mutations; prostate cancer genetics.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTERESTS

The authors declare that there are no conflicts of interests.

Similar articles

Cited by

References

    1. Bernstein AN, Shoag JE, Golan R, et al. Contemporary incidence and outcomes of prostate cancer lymph node metastases. J Urol. 2018; 199(6):1510–1517. - PMC - PubMed
    1. Howlader NNA, Krapcho M, Miller D, et al. SEER Cancer Statistics Review, 1975-2016. Bethesda, MD: National Cancer Institute; 2017. https://seer.cancer.gov/csr/1975_2015/
    1. Chamie K, deVere White RW, Lee D, Ok J, Ellison LM. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer. Cancer. 2008;113(9):2464–2470. - PubMed
    1. Grönberg H. Prostate cancer epidemiology. The Lancet. 2003; 361(9360):859–864. - PubMed
    1. Pritchard CC, Mateo J, Walsh MF, et al. Inherited DNA-repair gene mutations in men with metastatic prostate cancer. N Engl J Med. 2016; 375(5):443–453. - PMC - PubMed

Publication types